Ingalls & Snyder LLC Immuno Precise Antibodies Ltd. Transaction History
Ingalls & Snyder LLC
- $2.56 Billion
- Q3 2024
A detailed history of Ingalls & Snyder LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 1,558,892 shares of IPA stock, worth $530,023. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,558,892
Previous 1,295,441
20.34%
Holding current value
$530,023
Previous $1.31 Million
23.85%
% of portfolio
0.04%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding IPA
# of Institutions
19Shares Held
1.9MCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny60.3KShares$20,5020.0% of portfolio
-
Bank Of Montreal Toronto, A657.8KShares$19,6540.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$17,2480.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$14,0080.0% of portfolio
-
Gradient Capital Advisors, LLC26.8KShares$9,1140.01% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $8.44M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...